Artificial Intelligence in Diabetes Management Market Outlook 2025 – In-Depth Data for Business Expansion to 2034

 We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

 
 What is the current market size of the artificial intelligence in diabetes management industry, and what growth rate is it expected to achieve?
 The artificial intelligence in diabetes management market size has grown exponentially in recent years. It will grow from $0.62 billion in 2024 to $0.8 billion in 2025 at a compound annual growth rate (CAGR) of 30.2%. The growth in the historic period can be attributed to data accumulation, rising diabetes cases, healthcare cost pressures, early ai applications
 
 The artificial intelligence in diabetes management market size is expected to see exponential growth in the next few years. It will grow to $2.56 billion in 2029 at a compound annual growth rate (CAGR) of 33.7%. The growth in the forecast period can be attributed to ai-powered decision support systems, telemedicine integration, genomic data utilization, regulatory support. Major trends in the forecast period include advancements in wearable technology, personalized treatment plans, continuous glucose monitoring advances, ai-powered risk prediction, behavioral modification support.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=12593&type=smp
 
 What are the major drivers contributing to the growth of the artificial intelligence in diabetes management market?
 The rising prevalence of diabetes is expected to propel artificial intelligence in the diabetes management market going forward. Diabetes occurs when the blood glucose, or blood sugar, is too high. Diabetes is a condition that causes various conditions such as eye problems, heart attacks and strokes, kidney problems, and others. Artificial intelligence is used to manage diabetes as it provides information about high or low blood sugar levels in a diabetic patient and collects data that has not been used previously. For instance, in June 2024, according to National Health Service (NHS England), a UK-based publicly funded healthcare system, 3,615,330 people registered with a GP were found to have non-diabetic hyperglycaemia — also known as pre-diabetes -in 2023, compared to 3,065,825 in 2022 — an increase of almost a fifth (18%). Therefore, the rising prevalence of diabetes is driving the growth of artificial intelligence in the diabetes management market.
 
 What are the major market segments driving the growth of the artificial intelligence in diabetes management industry?
 The artificial intelligence in diabetes management market covered in this report is segmented –
 
 1) By Device: Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices
 2) By Techniques: Case-Based Reasoning, Intelligent Data Analysis
 3) By End-Use: Hospitals, Clinics, Home Care Settings, Research Institutes
 
 Subsegments:
 1) By Diagnostic Devices: Blood Glucose Meters, Continuous Glucose Monitors (CGMs), A1C Testing Devices, Urine Testing Devices
 2) By Glucose Monitoring Devices: Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Systems, Smart Glucose Meters
 3) By Insulin Delivery Devices: Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Smart Insulin Delivery Systems
 4) By Other Devices: Diabetes Management Apps, Wearable Devices, Smart Health Monitors, Insulin Refrigerators
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report
 
 What evolving trends are creating new opportunities in the artificial intelligence in diabetes management market?
 Technological advancements are a key trend gaining popularity in the artificial intelligence in diabetes management market. Major companies operating in the artificial intelligence in diabetes management market are focused on innovating new and advanced technological solutions to sustain their position in the market. For instance, in October 2022, Dr. Mohan’s Diabetes Specialties Center, an India-based diabetes specialty hospital chain, launched an innovative artificial intelligence-enabled platform for precision diabetes care with the 3D Initiative. The first of the three Ds is DIA, an AI-powered chatbot that can help individuals through pre-recorded digital interactions. The second is DIALA, a user-friendly smartphone app for patients; the last is DIANA, a medical app for precise diabetic care. According to the company, it is supported by the most advanced Total Experience (TX) Automation Platform, which powers an AI-enabled virtual assistant that interacts with patients on platforms such as Facebook Messenger, WhatsApp, Google Business Message, and the web.
 
 Who are the key market players contributing to the growth of the artificial intelligence in diabetes management industry?
 Major companies operating in the artificial intelligence in diabetes management market include Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifePlus Inc., Livongo Health Inc., Xeris Pharmaceuticals Inc., Virta Health Corp., Informed Data Systems Inc., Bigfoot Biomedical Inc., Lark Technologies Inc., Smart Meter LLC, Diabeloop SA, Quin Technology Ltd., Wellthy Therapeutics Pvt Ltd., Admetsys LLC, DreaMed Diabetes Ltd., Eyenuk Inc., Glooko Inc., PKvitality, Glytec LLC, Hygieia Inc., TypeZero Technologies Inc., Nemaura Medical Inc., GlucoMe, PredictBGL, Voluntis S.A.
 
 Which regions are leading the growth of the artificial intelligence in diabetes management market globally?
 North America was the largest region in the artificial intelligence (AI) in diabetes management market in 2024. The regions covered in the artificial intelligence in diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 How Can Companies Use The Artificial Intelligence in Diabetes Management Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12593
 
 Need Customized Data On Artificial Intelligence in Diabetes Management Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=12593&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company